ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2021
February 22, 2022 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, Feb. 22, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2021
February 16, 2022 06:30 ET
|
ImmuCell Corporation
PORTLAND, Maine, Feb. 16, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Record Preliminary, Unaudited Sales Results for the Year Ended December 31, 2021
January 05, 2022 06:30 ET
|
ImmuCell Corporation
PORTLAND, Maine, Jan. 05, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Unaudited Financial Results for the Third Quarter Ended September 30, 2021
November 15, 2021 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, Nov. 15, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell to Announce Unaudited Financial Results for the Third Quarter Ended September 30, 2021
November 09, 2021 16:00 ET
|
ImmuCell Corporation
PORTLAND, Maine, Nov. 09, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Record Preliminary, Unaudited Sales Results for Third Quarter of 2021
October 06, 2021 06:30 ET
|
ImmuCell Corporation
PORTLAND, Maine, Oct. 06, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
Raffael Lichdi, DVM Joins ImmuCell’s Sales & Marketing Team
September 14, 2021 06:30 ET
|
ImmuCell Corporation
PORTLAND, Maine, Sept. 14, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Required to Prepare Second Submission of Final Major Technical Section for Re-Tain®
August 24, 2021 06:30 ET
|
ImmuCell Corporation
PORTLAND, Maine, Aug. 24, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2021
August 12, 2021 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, Aug. 12, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell to Announce Unaudited Financial Results for the Second Quarter Ended June 30, 2021
August 05, 2021 06:30 ET
|
ImmuCell Corporation
PORTLAND, Maine, Aug. 05, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...